No More Finger Pricks: AI-Powered Smart Ring Revolutionizes Non-Invasive Blood Glucose Monitoring in China

For China's 140 million diabetes patients, monitoring blood sugar has long meant an uncomfortable ritual: prick the fingertip with a lancet, squeeze out a drop of blood, wait for the test strip to deliver a number. Many patients skip checks altogether — some because they fear the needle, others because the process feels too tedious to repeat day after day.

A ring-shaped device weighing just 15 grams, developed by Beijing-based Lepu Medical Technology (Beijing) Co., Ltd., promises to change that. The non-invasive glucose monitor, which slips onto a finger like a miniature smartwatch, recently received market approval from China's National Medical Products Administration (NMPA), clearing the way for patients to track their blood sugar without a single puncture.

No lancet. No test strip. Wear it for five minutes, and a companion smartphone app displays a glucose reading.

How It Works

The ring uses near-infrared multispectral technology — light waves that pass through the skin to measure glucose levels beneath the surface — paired with cloud-based artificial intelligence algorithms to process the data. According to the company, the measurement accuracy approaches that of minimally invasive glucose monitors currently on the market.

Beyond a single reading, the device tracks glucose fluctuations over a 15-day window, giving patients and their doctors a fuller picture of how blood sugar trends over time. When readings spike or drop abnormally, the ring sends proactive alerts to the user's phone.

A Growing Market Need

Diabetes, often called the "sweet killer," has become one of China's most pressing public health challenges. The country now has more than 140 million people living with the disease — a figure that continues to climb. Yet frequent glucose monitoring remains a sticking point: traditional finger-prick methods, while accurate, create friction that leads many patients to test less often than their condition demands.

A painless, hassle-free alternative could meaningfully improve adherence, particularly for the millions of patients who have scaled back monitoring out of discomfort or inconvenience.

What Comes Next

With NMPA approval secured, the ring-shaped glucose monitor is expected to reach consumers shortly. Lepu Medical, one of China's leading medical device companies, has not yet disclosed pricing details. The real test will be whether patients — and the doctors who treat them — trust a non-invasive reading enough to act on it. If the ring's AI-driven accuracy holds up in broader clinical use, it could mark a turning point in how 140 million Chinese patients manage a disease that demands constant vigilance.